Humanized antibodies that recognize beta amyloid peptide
US7256273B2 · kind B2 · utility
107Cited by
146References
55Claims
0Family size
Assignees
Inventors
Key dates
| Filing date | Mar 12, 2003 |
| Grant date | Aug 14, 2007 |
| Priority date | — |
| Expiry date | May 14, 2023 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07K2319/00
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The invention provides improved agents and methods for treatment of diseases associated with amyloid deposits of Aβ in the brain of a patient. Preferred agents include humanized antibodies.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.